What You Should Know: - Sidekick Health today announces the launch of an integrated digital therapeutics solution for improving the outcomes of patients with Atopic Dermatitis (AD) in conjunction with Pfizer Inc., one of the world's premier innovative biopharmaceutical companies. - Sidekick and Pfizer will be rolling out their integrated digital therapeutics offering, launching first in the UK, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022.
Read More
ePROs: Better Patient Input for Better Trial Output
During the pandemic, electronic clinical outcomes assessments (eCOAs) gained prominence as sponsors looked for more agile tools to help them capture patient data remotely through decentralized clinical trials (DCTs). From the adoption of virtual models like eCOAs and DCTs, a new opportunity emerged to enhance the patient experience. Decreasing the amount of time spent on on-site appointments helped reduce patient burden. Additionally, sponsors gained real-time insights on how patients interact
Read More
OncoHost Raises $35M for AI-Powered Precision Oncology Platform
What You Should Know: - OncoHost, an AI-powered precision oncology platform, today announced a $35M Series C funding round led by ALIVE Israel HealthTech VC, as well as other prominent investors. Additional investors included leading Israeli financial firm Leumi Partners, Israel’s largest pension fund Menora Mivtachim, OurCrowd and other existing investors. - The funding will go towards expanding OncoHost’s ongoing multicenter PROPHETIC trial as well as support its upcoming
Read More
Reify Health Secures $220M to Support Clinical Trial Diversity at $4.8B Valuation
What You Should Know: - Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D funding round dedicated to improving diversity in clinical research. The investment comes less than a year after its Series C and brings the company's valuation to $4.8B. - The Series C found was co-led by Altimeter Capital and Coatue, joined by Dragoneer Investment Group and existing investors ICONIQ Growth, Adams Street, and Battery
Read More
DaVita to Invest $15M in Biopharma Company Rockwell Medical
What You Should Know: - Rockwell Medical, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management expands its partnership with kidney care leader DaVita Inc. Rockwell Medical has been working to revise certain terms of its supply contracts with customers in an effort to stabilize its concentrates business. - The amended supply agreement is designed to enable Rockwell Medical's concentrates business the potential to operate
Read More
BrightInsight & UCB Partner to Build Digital Care Solutions for Rare Diseases
What You Should Know: - BrightInsight, provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced a partnership with global biopharma, UC to build digital care solutions for rare diseases. - BrightInsight will build and bring to market a digital disease management solution to support patients with Myasthenia Gravis (MG), a rare autoimmune disease that disrupts how nerves communicate with muscles, affecting more than 700,000 people
Read More
DarioHealth Forms $30M Strategic Agreement with Sanofi U.S.
What You Should Know: - DarioHealth Corp., a provider of global digital therapeutics (DTx), announced it has entered into a $30M multi-year, strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, $30 million-dollar agreement will help accelerate commercial adoption of Dario's full suite of digital therapeutics and drive the expansion of digital health solutions on the Dario platform. - As part of the strategic agreement, Dario and Sanofi will
Read More
ObvioHealth, RedHill Biopharma Launches First in Kind Remote COVID-19 Therapy Trial
What You Should Know: - RedHill Biopharma, a specialty biopharmaceutical company, and ObvioHealth, a global virtual research organization, have partnered on the largest remote clinical study for a new at-home COVID-19 treatment, Upamostat. - The trial is being performed completely remotely in patients’ homes using ObvioHealth’s clinical trial ecosystem including digital devices, a patient-centric smartphone application and home healthcare visits. - The randomized, double-blind,
Read More
AliveCor, AstraZeneca Partner to Screen for Blood Potassium Levels Via Electrocardiograms
What You Should Know: - AliveCor, a digital AI-based personal technology provider, and AstraZeneca, a global leader in the biopharmaceutical space, are working together to create more informed disease management solutions across cardiovascular, renal, and metabolism therapeutic areas. - The collaboration will focus on the development of AliveCor’s potassium detection technology through their Kardia-K AI platform, to screen for elevated levels of blood potassium via electrocardiograms.
Read More
Why Cancer Registries are Part of America’s Fight for Racial Equality
According to a 2019 study in the Proceedings of the National Academy of Sciences, one in 1,000 Black males can expect to die at the hands of the police. Black males were also 2.5 times more likely to die during an encounter with police than white males. For some, those figures are staggering. For many others, they are reminders of the racial disparities that have existed for far too long in this country. So, in 2020, when recent events have brought racial injustice back into the national
Read More
